Literature DB >> 19005468

Memory CD8 T-cell compartment grows in size with immunological experience.

Vaiva Vezys1, Andrew Yates, Kerry A Casey, Gibson Lanier, Rafi Ahmed, Rustom Antia, David Masopust.   

Abstract

Memory CD8 T cells, generated by natural pathogen exposure or intentional vaccination, protect the host against specific viral infections. It has long been proposed that the number of memory CD8 T cells in the host is inflexible, and that individual cells are constantly competing for limited space. Consequently, vaccines that introduce over-abundant quantities of memory CD8 T cells specific for an agent of interest could have catastrophic consequences for the host by displacing memory CD8 T cells specific for all previous infections. To test this paradigm, we developed a vaccination regimen in mice that introduced as many new long-lived memory CD8 T cells specific for a single vaccine antigen as there were memory CD8 T cells in the host before vaccination. Here we show that, in contrast to expectations, the size of the memory CD8 T-cell compartment doubled to accommodate these new cells, a change due solely to the addition of effector memory CD8 T cells. This increase did not affect the number of CD4 T cells, B cells or naive CD8 T cells, and pre-existing memory CD8 T cells specific for a previously encountered infection were largely preserved. Thus, the number of effector memory CD8 T cells in the mammalian host adapts according to immunological experience. Developing vaccines that abundantly introduce new memory CD8 T cells should not necessarily ablate pre-existing immunity to other infections.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19005468     DOI: 10.1038/nature07486

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  26 in total

Review 1.  Maintaining the status quo: T-cell homeostasis.

Authors:  Ananda W Goldrath
Journal:  Microbes Infect       Date:  2002-04       Impact factor: 2.700

Review 2.  Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know.

Authors:  Giuseppe Pantaleo; Richard A Koup
Journal:  Nat Med       Date:  2004-08       Impact factor: 53.440

Review 3.  The role of models in understanding CD8+ T-cell memory.

Authors:  Rustom Antia; Vitaly V Ganusov; Rafi Ahmed
Journal:  Nat Rev Immunol       Date:  2005-02       Impact factor: 53.106

4.  T cell subset-specific susceptibility to aging.

Authors:  Marta Czesnikiewicz-Guzik; Won-Woo Lee; Dapeng Cui; Yuko Hiruma; David L Lamar; Zhi-Zhang Yang; Joseph G Ouslander; Cornelia M Weyand; Jörg J Goronzy
Journal:  Clin Immunol       Date:  2008-01-28       Impact factor: 3.969

5.  AIDS research. Review of vaccine failure prompts a return to basics.

Authors:  Jocelyn Kaiser
Journal:  Science       Date:  2008-04-04       Impact factor: 47.728

6.  Dynamic phenotypic restructuring of the CD4 and CD8 T-cell subsets with age in healthy humans: a compartmental model analysis.

Authors:  D R Jackola; H M Hallgren
Journal:  Mech Ageing Dev       Date:  1998-11-16       Impact factor: 5.432

7.  Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections.

Authors:  L K Selin; K Vergilis; R M Welsh; S R Nahill
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

Review 8.  Cytokine control of memory T-cell development and survival.

Authors:  Kimberly S Schluns; Leo Lefrançois
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

9.  A critical role for CD40-CD40 ligand interactions in amplification of the mucosal CD8 T cell response.

Authors:  L Lefrançois; S Olson; D Masopust
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

10.  The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?

Authors:  Rafick-Pierre Sekaly
Journal:  J Exp Med       Date:  2008-01-14       Impact factor: 14.307

View more
  132 in total

Review 1.  Heterologous immunity between viruses.

Authors:  Raymond M Welsh; Jenny W Che; Michael A Brehm; Liisa K Selin
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant.

Authors:  Corinna La Rosa; Jeff Longmate; Simon F Lacey; Teodora Kaltcheva; Rahul Sharan; Denise Marsano; Peter Kwon; Jennifer Drake; Brenda Williams; Sharon Denison; Suenell Broyer; Larry Couture; Ryotaro Nakamura; Sanjeet Dadwal; Morris I Kelsey; Arthur M Krieg; Don J Diamond; John A Zaia
Journal:  J Infect Dis       Date:  2012-03-07       Impact factor: 5.226

3.  Moving ahead an HIV vaccine: use both arms to beat HIV.

Authors:  Bruce D Walker; Rafi Ahmed; Stanley Plotkin
Journal:  Nat Med       Date:  2011-10-11       Impact factor: 53.440

4.  The impact of pre-existing memory on differentiation of newly recruited naive CD8 T cells.

Authors:  Matthew D Martin; Thomas C Wirth; Peter Lauer; John T Harty; Vladimir P Badovinac
Journal:  J Immunol       Date:  2011-08-10       Impact factor: 5.422

5.  Derivation and maintenance of virtual memory CD8 T cells.

Authors:  Adovi D Akue; June-Yong Lee; Stephen C Jameson
Journal:  J Immunol       Date:  2012-02-03       Impact factor: 5.422

Review 6.  Coverage of related pathogenic species by multivalent and cross-protective vaccine design: arenaviruses as a model system.

Authors:  Jason Botten; John Sidney; Bianca R Mothé; Bjoern Peters; Alessandro Sette; Maya F Kotturi
Journal:  Microbiol Mol Biol Rev       Date:  2010-06       Impact factor: 11.056

7.  Murine superficial lymph node surgery.

Authors:  Mélissa Mathieu; Nathalie Labrecque
Journal:  J Vis Exp       Date:  2012-05-21       Impact factor: 1.355

Review 8.  Tissue-resident memory T cells: local specialists in immune defence.

Authors:  Scott N Mueller; Laura K Mackay
Journal:  Nat Rev Immunol       Date:  2015-12-21       Impact factor: 53.106

9.  Variable epitope library carrying heavily mutated survivin-derived CTL epitope variants as a new class of efficient vaccine immunogen tested in a mouse model of breast cancer.

Authors:  Allan NoeDominguez-Romero; Rubén Zamora-Alvarado; Rodolfo Servín-Blanco; Erendira G Pérez-Hernández; Laura E Castrillon-Rivera; Maria Elena Munguia; Gonzalo Acero; Tzipe Govezensky; Goar Gevorkian; Karen Manoutcharian
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

10.  Altered CD4+ T cell immunity in nurses occupationally exposed to viral pathogens.

Authors:  G Elias; A Souquette; S Heynderickx; I De Meester; H Jansens; P Beutels; P Van Damme; E Smits; P G Thomas; V Van Tendeloo; B Ogunjimi
Journal:  Clin Exp Immunol       Date:  2018-09-19       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.